Ms Arantxa Romero Toledo

Identification of HMGB1 as a novel therapeutic target for the treatment of chronic lymphocytic leukaemia. 

Supervisor:

Dr Li Jia
This site uses cookies in order to function properly. By continuing to browse, you agree that we can save them on your device. Privacy Policy.